Published studies, methods, evidence limits and the questions research can answer.
From the abstract: “This study examines the barriers and facilitators affecting both the provision and accessibility of developmental assessments by exploring the experiences of health professionals and parents of under–five children.”
From the abstract: “Data on demographics, comorbidities, stroke subtype, management, and outcomes were collected and analyzed using Python-based statistical libraries.”
From the abstract: “This study explored day-to-day experiences and challenges encountered during long-term warfarin use among patients with prosthetic heart valves attending a National Cardiac Institute in Dar es Salaam, Tanzania.”
From the abstract: “The objective of this study was to determine the prevalence, treatment rates and control of dyslipidemia among DM patients in northern Nigeria.”
From the abstract: “We conducted a pilot project at three health facilities in two districts in Zambia between September 2021 through July 2022 to demonstrate the feasibility of residual blood specimen collection integrated into the health system to estimate measles seroprevalence.”
From the abstract: “Time to treatment initiation over 6 months was statistically different (Kaplan Meier Log-rank test, p = 0.0064) with pregnant women lagging behind non-pregnant women.”
From the abstract: “Microdata relating to ownership of livestock animal species were sourced from various population-based survey programs which together cover the majority of LMICs and categorized.”
From the abstract: “This study assessed the prevalence and risk factors of BV in early pregnancy and examined its association with ABO in the middle belt of Ghana.”
From the abstract: “Hence, the present study aimed to evaluate the in vitro and in vivo antibacterial activities and to screen the phytochemical profile of the 80% methanol extract of E. cymosa leaves.”
From the abstract: “This study aimed to evaluate drug use patterns at Thika Level 5 Hospital in Kenya using World Health Organization (WHO) core drug use indicators.”